Article Text

Download PDFPDF
Improving early HIV diagnosis, treatment and care in Europe with healthcare provider specific HIV indicator condition list and audits
  1. Denise E Twisk1,
  2. Ivo K Joore1,
  3. Jan E A M van Bergen1,2
  1. 1Department of General Practice, Division Clinical Methods and Public Health, Academic Medical Center, Amsterdam, The Netherlands
  2. 2STI AIDS Netherlands (SOA AIDS Nederland), Amsterdam, The Netherlands
  1. Correspondence to Denise E Twisk, Department of General Practice, Division Clinical Methods and Public Health, Academic Medical Center, Meibergdreef 9, Amsterdam 1100 DE, The Netherlands; denise.twisk{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

European HIV testing numbers need to be improved for early HIV case finding. Recently, a Spanish study by Agustí et al1 showed an HIV testing rate of 18.6% following the 4 months after HIV indicator (IC) diagnosis. We performed similar secondary analyses with 102 newly diagnosed HIV cases (2002–2012) from six general practices located in a high HIV prevalence area in Amsterdam, the Netherlands.2 In the medical records of these patients, we found an HIV testing rate of 26.0% in the 3 months after IC diagnosis.

In the …

View Full Text


  • Contributors DET was involved in statistical analyses and writing the manuscript. IKJ and JEAMvB provided feedback and approved the manuscript for submission.

  • Funding This work was supported by a grant (reference: 2012074) of the Aids Fonds, Amsterdam, The Netherlands.

  • Competing interests None declared.

  • Ethics approval According to the Medical Research (Human Subjects) Act (WMO), formal approval for this research project by a medical ethics committee was not required. The academic GP network extracts data according to strict guidelines for the privacy protection of patients and GPs.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.